Community Pharmacy England (CPE) - News updates


Update – Pfizer brands now available as generics

Update 17/06/2025 – Correction to PIP codes in the table below. Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released generic equivalent versions instead. The table below includes the Pfizer products that have recently transitioned from brand to generic along with information on ordering [...] The post Update – Pfizer brands now available as generics appeared first on Community Pharmacy England.

Joint Primary Care Statement on the Spending Review

Following on from last week’s Spending Review announcement, Community Pharmacy England has joined forces with other national primary care bodies to reiterate our call on Government to prioritise DHSC spending allocations towards primary care. The joint statement, copied below, has been signed by Community Pharmacy England, the General Practitioner’s Committee England, the British Dental Association’s [...] The post Joint Primary Care Statement on the Spending Review appeared first on Community Pharmacy England.

Medicine Supply Notification: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens and Levemir® Penfill 100units/ml solution for injection 3ml cartridges

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens Levemir® Penfill® 100units/ml solution for injection 3ml cartridges MSN/2025/036 Tier 2 – medium impact Date of issue: 16/06/2025 Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection [...] The post Medicine Supply Notification: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens and Levemir® Penfill 100units/ml solution for injection 3ml cartridges appeared first on Community Pharmacy England.

Reminder: please ask your patients to give feedback on Pharmacy First

Several months ago Community Pharmacy England and Healthwatch England launched an online Pharmacy First patient survey that pharmacy owners can direct patients to after receiving the service. The aim of this collaboration is to collect patient feedback on the service to help inform service improvements and to help to quantify the value of the service [...] The post Reminder: please ask your patients to give feedback on Pharmacy First appeared first on Community Pharmacy England.

Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Venlafaxine 37.5mg modified-release tablets. MSN/2025/035 Tier 2 – medium impact Date of issue: 13th June 2025 Venlafaxine 37.5mg modified release (MR) tablets are out of stock until mid-July 2025. Venlafaxine 37.5mg MR capsules remain available and can support increased demand. Venlafaxine [...] The post Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets appeared first on Community Pharmacy England.

Yorkshire and North Eastern Pharmacy Owners: Book on your local Future of Pharmacy workshop

With the conclusion of the NHS 10-Year Health Plan imminent, this is a critical time for community pharmacy and it is important that we focus on the future, including looking at negotiating priorities to further leverage community pharmacy’s position. Pharmacy owners across Yorkshire and the Humber and the North East are invited to ‘Future of [...] The post Yorkshire and North Eastern Pharmacy Owners: Book on your local Future of Pharmacy workshop appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited)

MHRA Class 2 Medicines Notification: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) Drug alert number: EL(25)A/27 Date issued: 12 June 2025 Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton. [...] The post MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) appeared first on Community Pharmacy England.

DMS: Shortened claim journey on MYS from July 2025

A new streamlined process for making claims for the Discharge Medicines Service (DMS) will come into effect from 6th July 2025. Following feedback from Community Pharmacy England about the current lengthy claim process, NHS England and NHSBSA have agreed to introduce a shortened process for making claims for DMS. In time, an API will be [...] The post DMS: Shortened claim journey on MYS from July 2025 appeared first on Community Pharmacy England.

Government announces Spending Review Outcome

The Government’s Spending Review has concluded, with Chancellor Rachel Reeves today announcing the Government’s new spending priorities. The announcement included a 3% real terms uplift to NHS funding, for each of the coming three years, with the Government reiterating its commitment to its three shifts for healthcare: moving care closer to home, from treatment to [...] The post Government announces Spending Review Outcome appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare)

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets, Opella Healthcare Drug alert number: EL(25)A/26 Date issued: 10 June 2025 Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax® Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states [...] The post MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare) appeared first on Community Pharmacy England.